S. Mishima Gerhart

S. Mishima Gerhart has extensive experience in regulatory affairs and quality management. They are currently serving as the Chief Regulatory Officer and Head of Quality at Taysha Gene Therapies since June 2020. Prior to this, they held various leadership positions at Sanofi, including Vice President and Head of Global Regulatory Affairs for General Medicines and Emerging Markets from January 2016 to June 2020, and Vice President and Head of Global Regulatory Affairs from April 2014 to January 2016. Before joining Sanofi, they worked at AbbVie as a Senior Director in Regulatory Affairs and Global Product Strategy from March 2013 to April 2014. They also held the position of AVP Regulatory Affairs at Reata Pharmaceuticals from February 2012 to March 2013. Earlier in their career, they were employed at Pfizer as a Senior Director in Global Regulatory Affairs from 2000 to 2012 and at Wyeth Research as an Associate Director from 2000 to 2009. They also worked at AstraZeneca Pharmaceuticals as a Regulatory Project Manager from 2003 to 2006. Their career started in the medical products industry, specifically at Scott Specialty Gases as a QA & Reg Lab Technician from January 2000 to November 2000, and at Houghton International as a Department of Hydraulics Lab Technician from August 1998 to January 2000.

S. Mishima Gerhart obtained a Bachelor of Science degree in Microbiology/Cell Biology from Kutztown University of Pennsylvania, where they studied from 1993 to 1998. Later, they pursued a Master of Science degree in Regulatory affairs/Quality assurance at Temple University from 2001 to 2004.